6505-00-171-1187 (DIABINESE, NDC00069-3940-41, NDC00663-3940-41) Data

6505-00-171-1187 (6505001711187) NSN Information

NSNFSCNIINItem NameINC
6505-00-171-11876505001711187Chlorpropamide Tablets27883

6505-00-171-1187 Features

MRCParameterCharacteristics
AKJAActive Medicament Medicinal Strength250.000 milligrams chlorpropamide active ingredient
CBBLFeatures ProvidedIndividually sealed
CQCTPrimary Container TypeStrip
CRLKPrimary Container Content Quantity100.000 tablets
CSCWTotal Primary Container Quantity1
FEATSpecial Features100 tablets
MDESMedical Designation and GradeUnited states pharmacopeia
SUPPSupplementary FeaturesMedsep item for dod, pfizer inc

6505-00-171-1187 Manufacturing Part Numbers (SKUs)

MFG SKUCAGESTATUSISCRNVCRNCCSADCDACHCCRNAAC
DIABINESE86491A13 75
NDC00069-3940-4186491A95 ZZ
NDC00663-3940-4186491A95 54

6505-00-171-1187 Manufacturer

MFG SKUCAGEManufacturerTypeStatusRole
DIABINESE86491Pfizer Inc.AA
NDC00069-3940-4186491Pfizer Inc.AA
NDC00663-3940-4186491Pfizer Inc.AA

6505-00-171-1187 FLIS Identification

PMICADPE CODECRITL CODEDEMIL CODEDEMIL INTGNIIN ASGMTESDHMICENACSCHEDULE_BINC
AXA114-FEB-1973P300431000027883

6505-00-171-1187 FLIS Management

MOEREC REP CODEMGMT CTLUSCPHRASE CODEPHRASE STATEMENT
VA-------V

6505-00-171-1187 Demilitarization Codes & Management

DMLPMICHMICADPECCriticalityESDC
APX

6505-00-171-1187 Miscellaneous Management

MOE (S_A)SOSAACQUPUISLCCIICRCMCCSVC
VAG36GBPGQU-------V

6505-00-171-1187 Non-consumable Item Support

MOE RULENIMSCDSOR
G572
G652
V542

6505-00-171-1187 Freight

NMFCNMFC SUBUFCHMCLTLLCLWCCTCCSHCADCACCASHNMF DESC

6505-00-171-1187 FLIS Packaging 1

PICA SICATOSICQMOPCLNG DRYINGPRES MATWRAP MATPKG CATPKG DESIGN ACTYCUSH DUN
PZZZZZZZZZ

6505-00-171-1187 FLIS Packaging 2

THKUNIT CONTPKG DATA SOURCEINTER CONTUCLSPC MKGLVL ALVL BLVL C
ZZZA

6505-00-171-1187 FLIS Packaging 3

UNIT PACK WEIGHTUNIT PACK SIZEUNIT PACK CUBECONT NSNOPIUNPKG ITEM DIMUNPKG ITEM WEIGHTSPI DATESPI NOSPI REVSUPPL INSTR
0000.30000.055